So, sure, so what we've really been focused on is part of the deal is really what these companies can do together, and the transaction is really bringing the complementary strengths of both of the companies, if we look at those product lines and the opportunity, is really maintaining the core, what is CBOE what have we done in the past and that is to bring to the marketplace, all of the products services benchmarks that we have done in the past, we will not lose side of that. Bats as the of second largest U.S. operator in U.S. equities, operating a platform in Europe, that combination allows us from a business developer perspective, to reach a cross to cross sell to develop new products and services that we wouldn't be able to do together. I love to give you a great example of businesses that we have been involved with in the past, and specifically, we've been very much partners with ETP providers, and I think the greatest example of that for us, is partnering with Barclays and the VXX the most successful for us, when we look at volatility ETP's that been brought to the market. In partnering and helping design at being an integral part in bringing it at concept like ETP to market, or ETN to market, we haven't participated in the volume related to that ETN or ETP training, with Bats listing platform, conceptually we can take the idea of a new ETN or ETP, right from the force of that idea, developed with our partner list that ETN or ETP on our new listing exchange, participate that in the volume resulting from the trading of the ETP, the construction and the index services around that ETN or ETP, and that is a back end, participate on the market data as a result, so this ecosystem for CBOE and product development now beginning with the concept moving to listing all the way to market data, changes because of this combination. Both of our companies really couldn't do this alone, but that's an example of some of the opportunities that we look forward to working with our new partner.